Vaccitech PLC ADR

Company Profile

Vaccitech PLC ADR had its IPO on 2021-04-30 under the ticker symbol VACC.

The company operates in the Healthcare sector and Biotechnology industry. Vaccitech PLC ADR has a staff strength of 33 employees.

Stock update

Shares of Vaccitech PLC ADR opened at $1.85 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.8 - $1.86, and closed at $1.85.

This is a +2.21% increase from the previous day's closing price.

A total volume of 4,684 shares were traded at the close of the day’s session.

In the last one week, shares of Vaccitech PLC ADR have slipped by -9.31%.

Vaccitech PLC ADR's Key Ratios

Vaccitech PLC ADR has a market cap of $77.05 million, indicating a price to book ratio of 0.3594 and a price to sales ratio of 2.3112.

In the last 12-months Vaccitech PLC ADR’s revenue was $13.42 million with a gross profit of $44.70 million and an EBITDA of $-62911000. The EBITDA ratio measures Vaccitech PLC ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vaccitech PLC ADR’s operating margin was -481.2% while its return on assets stood at -15.2% with a return of equity of -23.29%.

In Q2, Vaccitech PLC ADR’s quarterly earnings growth was a positive 0% while revenue growth was a negative 98%.

Vaccitech PLC ADR’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vaccitech PLC ADR’s profitability.

Vaccitech PLC ADR stock is trading at a EV to sales ratio of 1.5058 and a EV to EBITDA ratio of -9.068. Its price to sales ratio in the trailing 12-months stood at 2.3112.

Vaccitech PLC ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$246.13 million

Total Liabilities

$12.11 million

Operating Cash Flow

$0

Capital Expenditure

$3.02 million

Dividend Payout Ratio

0%

Vaccitech PLC ADR ended 2024 with $246.13 million in total assets and $0 in total liabilities. Its intangible assets were valued at $246.13 million while shareholder equity stood at $217.21 million.

Vaccitech PLC ADR ended 2024 with $0 in deferred long-term liabilities, $12.11 million in other current liabilities, 1000.00 in common stock, $-145225000.00 in retained earnings and $12.21 million in goodwill. Its cash balance stood at $173.03 million and cash and short-term investments were $173.03 million. The company’s total short-term debt was $1,135,000 while long-term debt stood at $0.

Vaccitech PLC ADR’s total current assets stands at $184.78 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $10.30 million compared to accounts payable of $2.43 million and inventory worth $0.

In 2024, Vaccitech PLC ADR's operating cash flow was $0 while its capital expenditure stood at $3.02 million.

Comparatively, Vaccitech PLC ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.85

52-Week High

$3.838

52-Week Low

$1.75

Analyst Target Price

$12.33

Vaccitech PLC ADR stock is currently trading at $1.85 per share. It touched a 52-week high of $3.838 and a 52-week low of $3.838. Analysts tracking the stock have a 12-month average target price of $12.33.

Its 50-day moving average was $2.13 and 200-day moving average was $2.43 The short ratio stood at 0.72 indicating a short percent outstanding of 0%.

Around 345.7% of the company’s stock are held by insiders while 4983.7% are held by institutions.